biib
来源:
rimm
于
2021-04-19 20:52:45
[
博客
] [
旧帖
] [
给我悄悄话
] 本文已被阅读:次
18-Month, Pre-Specified Analysis Showing Consistent Reduction in Clinical Outcome Measures from a Lecanemab (BAN2401) Phase 2b Clinical Trial in Early Alzheimer's Disease Published in Peer-Reviewed Journal, Alzheimer's Research and Therapy